Pregled bibliografske jedinice broj: 189483
Naphthalan in the treatment of patients with neurodermitis
Naphthalan in the treatment of patients with neurodermitis // Acta Dermatovenerologica Croatica
Zagreb: Grafoplast, 2002. str. 110-110 (predavanje, međunarodna recenzija, sažetak, stručni)
CROSBI ID: 189483 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Naphthalan in the treatment of patients with neurodermitis
Autori
Smeh-Skrbin, Ankica ; Dobrić, Ivan ; Krnjević-Pezić, Gordana ; Vržogić, Pero
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
Acta Dermatovenerologica Croatica
/ - Zagreb : Grafoplast, 2002, 110-110
Skup
2nd Congress of Croatian Dermatovenerologists in Dermatovenerology, New Highlights in Dermatovenerology
Mjesto i datum
Opatija, Hrvatska, 16.05.2002. - 19.05.2002
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
naphthalan; antiinflammatory and antiproliferative effect
Sažetak
Guided by the results of the study using naphthalan in the treatment of psoriasis (i.e. its antiinflammatory and antiproliferative effect), and stimulated by the satisfactory, months-long remissions in more than 70% of treated patients, we decided to examine the efficacy of naphthalan in the treatment of patients with atopic dermatitis. The study included 15 patients aged >15 with different clinical forms of atopic dermatitis. Naphthalan therapy has been applied for 3 weeks. During this period, the patients were taking baths in tubs containing naphthalan oil (temperature 34-38º ; ; ; C) every day for 12-14 minutes. This is the usual therapy that has been practiced for 12 years in the treatment of patients with psoriasis and rheumatic disease. Besides naphthalan baths, the patients were also applying neutral cream and were administered oral antihistaminics. Evaluation of therapeutic results included clinical evaluation (photographs taken before and after the 3-week therapy) ; SCORAD Index (Severity scoring of atopic dermatitis)-before and after the 3-week therapy ; histologic evaluation ; total IgE ; and laboratory tests After the 3-week naphthalan therapy, all patients experienced improvement in the form of reduction or disappearance of itching and sleeping disorders. The mean SCORAD Index was 71.92 before therapy and 25.66 after the 3-week therapy. Histologic findings showed no signs consistent with atopic dermatitis. Standard laboratory analysis showed no values that would suggest nephrotoxicity, hematotoxicity or hepatotoxicity due to naphthalan oil.
Izvorni jezik
Engleski